JP2004508366A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004508366A5 JP2004508366A5 JP2002525134A JP2002525134A JP2004508366A5 JP 2004508366 A5 JP2004508366 A5 JP 2004508366A5 JP 2002525134 A JP2002525134 A JP 2002525134A JP 2002525134 A JP2002525134 A JP 2002525134A JP 2004508366 A5 JP2004508366 A5 JP 2004508366A5
- Authority
- JP
- Japan
- Prior art keywords
- dihydro
- solvate
- salt
- functional derivative
- physiologically functional
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000003839 salts Chemical class 0.000 claims 6
- 239000012453 solvate Substances 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 4
- 150000001875 compounds Chemical class 0.000 claims 4
- 239000001257 hydrogen Substances 0.000 claims 4
- 229910052739 hydrogen Inorganic materials 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 2
- 208000035475 disorder Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 230000001404 mediated effect Effects 0.000 claims 2
- KMHXVUCYJPXSIV-DHDCSXOGSA-N (3z)-3-[[4-(1,2,4-triazol-1-yl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C\NC(C=C1)=CC=C1N1C=NC=N1 KMHXVUCYJPXSIV-DHDCSXOGSA-N 0.000 claims 1
- XAHMAJJMFALGCW-ZROIWOOFSA-N (3z)-3-[[4-(1h-1,2,4-triazol-5-yl)anilino]methylidene]-1h-indol-2-one Chemical compound O=C1NC2=CC=CC=C2\C1=C\NC(C=C1)=CC=C1C=1N=CNN=1 XAHMAJJMFALGCW-ZROIWOOFSA-N 0.000 claims 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical group C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 claims 1
- HSHFQBBHYFYCQC-LGMDPLHJSA-N 3-ethyl-3-[4-[[(z)-(2-oxo-1h-indol-3-ylidene)methyl]amino]phenyl]piperidine-2,6-dione Chemical compound C=1C=C(N\C=C/2C3=CC=CC=C3NC\2=O)C=CC=1C1(CC)CCC(=O)NC1=O HSHFQBBHYFYCQC-LGMDPLHJSA-N 0.000 claims 1
- WPAUHINVDSQAEQ-FLIBITNWSA-N 5-[[(z)-(2-oxo-1h-indol-3-ylidene)methyl]amino]-1,3-dihydrobenzimidazol-2-one Chemical compound C1=C2NC(=O)NC2=CC(N/C=C2/C3=CC=CC=C3NC2=O)=C1 WPAUHINVDSQAEQ-FLIBITNWSA-N 0.000 claims 1
- 101150111783 NTRK1 gene Proteins 0.000 claims 1
- JUULZRNMGDKYCG-YFHOEESVSA-N O1C(N)=NN=C1C1=CC=CC(N\C=C/2C3=C4N=NNC4=CC=C3NC\2=O)=C1 Chemical compound O1C(N)=NN=C1C1=CC=CC(N\C=C/2C3=C4N=NNC4=CC=C3NC\2=O)=C1 JUULZRNMGDKYCG-YFHOEESVSA-N 0.000 claims 1
- 108091000080 Phosphotransferase Proteins 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000003226 mitogen Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 102000020233 phosphotransferase Human genes 0.000 claims 1
- 230000035790 physiological processes and functions Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N urea group Chemical group NC(=O)N XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US22996600P | 2000-09-01 | 2000-09-01 | |
| PCT/US2001/026286 WO2002020513A1 (en) | 2000-09-01 | 2001-08-23 | Oxindole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004508366A JP2004508366A (ja) | 2004-03-18 |
| JP2004508366A5 true JP2004508366A5 (cg-RX-API-DMAC7.html) | 2005-05-19 |
Family
ID=22863416
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002525134A Pending JP2004508366A (ja) | 2000-09-01 | 2001-08-23 | オキシインドール誘導体 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US6964977B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1317446A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2004508366A (cg-RX-API-DMAC7.html) |
| AU (1) | AU8664701A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2002020513A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9904933D0 (en) * | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Compounds |
| JP4584713B2 (ja) | 2002-10-08 | 2010-11-24 | ライナット ニューロサイエンス コーポレイション | 神経成長因子アンタゴニストを投与することによって術後疼痛を処置するための方法および神経成長因子アンタゴニストを含有する組成物 |
| WO2005000194A2 (en) | 2002-10-08 | 2005-01-06 | Rinat Neuroscience Corp. | Methods for treating post-surgical pain by administering an anti-nerve growth factor antagonist antibody and compositions containing the same |
| US7569364B2 (en) | 2002-12-24 | 2009-08-04 | Pfizer Inc. | Anti-NGF antibodies and methods using same |
| EA011479B1 (ru) | 2002-12-24 | 2009-04-28 | Ринат Ньюросайенс Корп. | Антитело связывающееся с ngf, и способы его применения |
| US9498530B2 (en) | 2002-12-24 | 2016-11-22 | Rinat Neuroscience Corp. | Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the same |
| US7815789B2 (en) | 2003-06-23 | 2010-10-19 | Shell Oil Company | Process to prepare a lubricating base oil |
| MXPA06011463A (es) | 2004-04-07 | 2007-04-25 | Rinat Neuroscience Corp | Metodos para tratar dolor por cancer de hueso al administrar un antagonista de factor de crecimiento de nervio. |
| WO2005118551A2 (en) * | 2004-05-28 | 2005-12-15 | Ligand Pharmaceuticals Inc. | Thrombopoietin activity modulating compounds and methods |
| US7314887B2 (en) * | 2004-10-25 | 2008-01-01 | Ligand Pharmaceuticals, Inc. | Thrombopoietin activity modulating compounds and methods |
| ES2555063T3 (es) | 2005-02-04 | 2015-12-28 | Astrazeneca Ab | Derivados de pirazolilaminopiridina útiles como inhibidores de quinasas |
| PL1853588T3 (pl) | 2005-02-16 | 2008-11-28 | Astrazeneca Ab | Związki chemiczne |
| NZ564317A (en) | 2005-05-16 | 2011-01-28 | Astrazeneca Ab | Pyrazolylaminopyrimidine derivatives useful as tyrosine kinase inhibitors |
| BRPI0618011A2 (pt) | 2005-10-28 | 2011-08-16 | Astrazeneca Ab | composto ou um sal farmaceuticamente aceitável do mesmo, processo para a preparação do mesmo, composição farmacêutica, uso de um composto ou um sal farmaceuticamente aceitável do mesmo, e, métodos para produzir um efeito anti-proliferativo e um efeito pró-apoptósico em um animal de sangue quente, para tratar doença e para produzir um efeito inibidor de jak em um animal de sangue quente |
| US8163746B2 (en) | 2006-04-19 | 2012-04-24 | Astellas Pharma Inc. | Azolecarboxamide derivative |
| TW200826937A (en) * | 2006-11-01 | 2008-07-01 | Astrazeneca Ab | New use |
| PT2206707E (pt) | 2007-10-24 | 2014-09-25 | Astellas Pharma Inc | Composto de azolcarboxamida ou um seu sal |
| JP5240205B2 (ja) | 2008-01-11 | 2013-07-17 | アステラス製薬株式会社 | 精巣の疼痛又は不快感行動及び頻尿併発モデル動物 |
| WO2009135000A2 (en) * | 2008-04-30 | 2009-11-05 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Inhibition of shp2/ptpn11 protein tyrosine phosphatase by nsc-117199 and analogs |
| TWI585088B (zh) | 2012-06-04 | 2017-06-01 | 第一三共股份有限公司 | 作爲激酶抑制劑之咪唑并［１，２－ｂ］嗒衍生物 |
| US9718775B2 (en) * | 2014-03-14 | 2017-08-01 | Milliken & Company | Oxindole compounds and compositions comprising the same |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9718913D0 (en) * | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
| DE19824922A1 (de) * | 1998-06-04 | 1999-12-09 | Boehringer Ingelheim Pharma | Neue substituierte Indolinone, ihre Herstellung und ihre Verwendung als Arzneimittel |
| US6498176B1 (en) * | 1999-03-04 | 2002-12-24 | Smithklinebeecham Corporation | 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
| US6624171B1 (en) * | 1999-03-04 | 2003-09-23 | Smithkline Beecham Corporation | Substituted aza-oxindole derivatives |
| GB9904933D0 (en) | 1999-03-04 | 1999-04-28 | Glaxo Group Ltd | Compounds |
| US6492398B1 (en) * | 1999-03-04 | 2002-12-10 | Smithkline Beechman Corporation | Thiazoloindolinone compounds |
| US6620818B1 (en) * | 2000-03-01 | 2003-09-16 | Smithkline Beecham Corporation | Method for reducing the severity of side effects of chemotherapy and/or radiation therapy |
| ATE343575T1 (de) | 2001-09-27 | 2006-11-15 | Smithkline Beecham Corp | Azaoxoindol derivate als trk protein kinase hemmstoffe zur behandlung von krebs und chronischem schmerz |
-
2001
- 2001-08-23 WO PCT/US2001/026286 patent/WO2002020513A1/en not_active Ceased
- 2001-08-23 AU AU8664701A patent/AU8664701A/xx active Pending
- 2001-08-23 US US10/362,739 patent/US6964977B2/en not_active Expired - Fee Related
- 2001-08-23 JP JP2002525134A patent/JP2004508366A/ja active Pending
- 2001-08-23 EP EP01966107A patent/EP1317446A1/en not_active Withdrawn
-
2005
- 2005-08-03 US US11/196,597 patent/US20050282810A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004508366A5 (cg-RX-API-DMAC7.html) | ||
| TWI699359B (zh) | ４ｈ-吡咯［３,２-ｃ］吡啶-４-酮衍生物 | |
| ES2206292T3 (es) | Derivados de oxazol y tiazol como agentes activadores de la produccion/secrecion de neurotrofina. | |
| CA2823877C (en) | Novel pyrazole and imidazole derivatives useful as orexin antagonists | |
| JP4974438B2 (ja) | ファルネシルトランスフェラーゼを阻害する６−ヘテロシクリルメチルキノリンおよびキナゾリン誘導体 | |
| JP2020530446A5 (cg-RX-API-DMAC7.html) | ||
| JP5647268B2 (ja) | 新規抗真菌性トリアゾール誘導体 | |
| JP2019077725A5 (cg-RX-API-DMAC7.html) | ||
| US20080166359A1 (en) | Methods of using MEK inhibitors | |
| AU2009266756B2 (en) | Triazole derivative or salt thereof | |
| RU2008141761A (ru) | ИНГИБИТОРЫ с-МЕТ ПРОТЕИНКИНАЗЫ | |
| US20090137596A1 (en) | G-protein inhibitor | |
| JP4974437B2 (ja) | ファルネシルトランスフェラーゼを阻害する６−［（置換フェニル）メチル］−キノリンおよびキナゾリン誘導体 | |
| JP2005525324A5 (cg-RX-API-DMAC7.html) | ||
| RU2003107016A (ru) | Замещенные пиразолы | |
| JP2008520741A5 (cg-RX-API-DMAC7.html) | ||
| JP2013501749A5 (cg-RX-API-DMAC7.html) | ||
| JP2014517833A5 (cg-RX-API-DMAC7.html) | ||
| JP2004517848A (ja) | 抗ウイルス剤 | |
| CA2571627A1 (en) | Substituted aryl-amine derivatives and methods of use | |
| JP2009528389A5 (cg-RX-API-DMAC7.html) | ||
| JP2008507539A5 (cg-RX-API-DMAC7.html) | ||
| JP2009538321A5 (cg-RX-API-DMAC7.html) | ||
| RU2006127575A (ru) | Соединение триазола и их применение в качестве антагонистов метаботропного рецептора глутамата | |
| JP2003511384A5 (cg-RX-API-DMAC7.html) |